Effects of DL-homocysteine thiolactone on cardiac contractility, coronary flow, and oxidative stress markers in the isolated rat heart: The role of different gasotransmitters

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Zivkovic, Vladimir ^a   Jakovljevic, Vladimir ^a   Pechanova, Olga ^b   Srejovic, Ivan ^a   Joksimovic, Jovana ^a   Selakovic, Dragica ^a   Barudzic, Nevena ^a   Djuric, Dragan M ^c  

^a University of Kragujevac Medical Faculty   (Serbia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DRUG DERIVATIVE; GASOTRANSMITTER; HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONE; HYDROGEN PEROXIDE;

ANIMAL; ARTICLE; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; HEART; HEART CONTRACTION; HEART MUSCLE; MALE; METABOLISM; MUSCLE CONTRACTION; OXIDATIVE STRESS; RAT; WISTAR RAT;

ANIMALS; BIOLOGICAL MARKERS; CORONARY CIRCULATION; GASOTRANSMITTERS; HEART; HOMOCYSTEINE; HYDROGEN PEROXIDE; MALE; MUSCLE CONTRACTION; MYOCARDIAL CONTRACTION; MYOCARDIUM; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 84893788993     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/318471     Document Type: Article

References (73)

1. Smith Jr S. C., Collins A., Ferrari R., Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). Journal of the American College of Cardiology 2012 60 22 2343 2348
2. Wilson P. W. F., D'Agostino R. B., Levy D., Belanger A. M., Silbershatz H., Kannel W. B., Prediction of coronary heart disease using risk fact (Pubitemid 28213628)
3. Heneghan H. M., Sultan S., Homocysteine, the cholesterol of the 21st century. Impact of hyperhomocysteinemia on patency and amputation-free survival after intervention for critical limb ischemia. Journal of Endovascular Therapy 2008 15 4 399 407 2-s2.0-49549089549 10.1583/08-2385.1
4. Kaplan E. D., Association between homocyst(e)ine levels and risk of vascular events. Drugs of Today 2003 39 3 175 191 2-s2.0-0037368292 10.1358/dot.2003.39.3.799452 (Pubitemid 36514357)
5. The Homocysteine Studies Collaboration, Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. The Journal of the American Medical Association 2015 288 16
6. Jakubowski H., Metabolism of homocysteine thiolactone in human cell cultures: possible mechanism for pathological consequences of elevated homocysteine levels. The Journal of Biological Chemistry 1997 272 3 1935 1942 2-s2.0-0031035742 (Pubitemid 27043288)
7. 2+-ATPases in rats subjected to acute homocysteine and homocysteine thiolactone administration. Molecular and Cellular Biochemistry 2009 327 1-2 39 45
8. Refsum H., Ueland P. M., Nygård O., Vollset S. E., Homocysteine and cardiovascular disease. Annual Review of Medicine 1998 49 31 62 2-s2.0-0031958860 10.1146/annurev.med.49.1.31 (Pubitemid 28197439)
9. Allen R. H., Stabler S. P., Savage D. G., Lindenbaum J., Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency. The FASEB Journal 1993 7 14 1344 1353 2-s2.0-0027423427 (Pubitemid 23336162)
10. Harker L. A., Ross R., Slichter S. J., Scott C. R., Homocystine induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. Journal of Clinical Investigation 1976 58 3 731 741 2-s2.0-0017197285
11. Wall R. T., Harlan J. M., Harker L. A., Striker G. E., Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thrombosis Research 1980 18 1-2 113 121 2-s2.0-0018858624 (Pubitemid 10109903)
12. Starkebaum G., Harlan J. M., Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. Journal of Clinical Investigation 1986 77 4 1370 1376 2-s2.0-0022552919 (Pubitemid 16047161)
13. Lang D., Kredan M. B., Moat S. J., Hussain S. A., Powell C. A., Bellamy M. F., Powers H. J., Lewis M. J., Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: role for superoxide anions. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 2 422 427 2-s2.0-0033961048 (Pubitemid 30086099)
14. Cohen R. A., Vanhoutte P. M., Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation 1995 92 11 3337 3349 2-s2.0-0028789274
15. Flesch M., Kilter H., Cremers B., Lenz O., Südkamp M., Kuhn-Regnier F., Böhm M., Acute effects of nitric oxide and cyclic GMP on human myocardial contractility. Journal of Pharmacology and Experimental Therapeutics 1997 281 3 1340 1349 2-s2.0-0030917959 (Pubitemid 27258394)
16. Paulus W. J., The role of nitric oxide in the failing heart. Heart Failure Reviews 2001 6 2 105 118 2-s2.0-0035059318 10.1023/A:1011453809750 (Pubitemid 32328173)
17. Drexler H., Kästner S., Strobel A., Studer R., Brodde O. E., Hasenfuß G., Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. Journal of the American College of Cardiology 1998 32 4 955 963 2-s2.0-0032192130 10.1016/S0735-1097(98) 00336-2 (Pubitemid 28459584)
18. Node K., Kitakaze M., Yoshihara F., Sasaki T., Kuzuya T., Hori M., Increased cardiac levels of nitric oxide in patients with chronic heart failure. American Journal of Cardiology 2000 86 4 474 477 2-s2.0-0034663708 10.1016/S0002-9149(00)00973-5 (Pubitemid 30628624)
19. Jakovljevic V. L., Djuric D. M., The effects on nitric oxide synthase-versus lipoxygenase inhibition on coronary flow and nitrite outflow in isolated rat heart. General Physiology and Biophysics 2005 24 2 199 207 2-s2.0-23944446070 (Pubitemid 41195317)
20. Cai H., Harrison D. G., Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circulation Research 2000 87 10 840 844 2-s2.0-0034634281
21. Ali M. Y., Ping C. Y., Mok Y.-Y. P., Ling L., Whiteman M., Bhatia M., Moore P. K., Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? British Journal of Pharmacology 2006 149 6 625 634 2-s2.0-33750967344 10.1038/sj.bjp.0706906 (Pubitemid 44748055)
22. Laggner H., Muellner M. K., Schreier S., Sturm B., Hermann M., Exner M., Gmeiner B. M. K., Kapiotis S., Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl. Free Radical Research 2007 41 7 741 747 2-s2.0-34347259271 10.1080/10715760701263265 (Pubitemid 46995255)
23. Whiteman M., Armstrong J. S., Chu S. H., Jia-Ling S., Wong B.-S., Cheung N. S., Halliwell B., Moore P. K., The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite "scavenger"? Journal of Neurochemistry 2004 90 3 765 768 2-s2.0-3343017187 10.1111/j.1471-4159.2004.02617.x (Pubitemid 38989409)
24. Whiteman M., Cheung N. S., Zhu Y.-Z., Chu S. H., Siau J. L., Wong B. S., Armstrong J. S., Moore P. K., Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? Biochemical and Biophysical Research Communications 2005 326 4 794 798 2-s2.0-10644266135 10.1016/j.bbrc.2004.11.110 (Pubitemid 39655989)
25. Whiteman M., Li L., Kostetski I., Chu S. H., Siau J. L., Bhatia M., Moore P. K., Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochemical and Biophysical Research Communications 2006 343 1 303 310 2-s2.0-33645102456 10.1016/j.bbrc.2006.02.154
26. Abraham N. G., Peterson S. J., Frishman W. H., Targeting heme oxygenase: therapeutic implications for diseases of the cardiovascular system. Cardiology in Review 2009 17 4 191 2-s2.0-68049100390 10.1097/CRD.0b013e3181af5141
27. Bauer M., Huse K., Settmacher U., Claus R. A., The heme oxygenase-carbon monoxide system: regulation and role in stress response and organ failure. Intensive Care Medicine 2008 34 4 640 648 2-s2.0-43349090130 10.1007/s00134-008-1010-2
28. Zivkovic V., Jakovljevic V., Djordjevic D., Vuletic M., Barudzic N., Djuric D., The effects of homocysteine-related compounds on cardiac contractility, coronary flow, and oxidative stress markers in isolated rat heart. Molecular and Cellular Biochemistry 2012 370 1-2 59 67
29. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979 95 2 351 358 2-s2.0-0018384650 (Pubitemid 9194347)
30. Green L. C., Wagner D. A., Glogowski J., Skipper P. L., Wishnok J. S., Tannenbaum S. R., Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Analytical Biochemistry 1982 126 1 131 138 2-s2.0-0020448709 (Pubitemid 13203451)
31. Auclair C., Voisin E., Greenwald R. A., Nitroblue tetrazolium reduction. Handbook of Methods for Oxygen Radical Research 1985 Boca Raton, Fla, USA CRC Press 123 132
32. Pick E., Keisari Y., A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. Journal of Immunological Methods 1980 38 1-2 161 170 2-s2.0-0019140628 (Pubitemid 11251411)
33. Moshal K. S., Kumar M., Tyagi N., Mishra P. K., Metreveli N., Rodriguez W. E., Tyagi S. C., Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1. American Journal of Physiology: Heart and Circulatory Physiology 2009 296 3 H887 H892 2-s2.0-64049097756 10.1152/ajpheart.00750.2008
34. Gao X., Xu X., Pang J., Zhang C., Ding J. M., Peng X., Liu Y., Cao J.-M., NMDA receptor activation induces mitochondrial dysfunction, oxidative stress and apoptosis in cultured neonatal rat cardiomyocytes. Physiological Research 2007 56 5 559 569 2-s2.0-36849000444
35. Moshal K. S., Tipparaju S. M., Vacek T. P., Kumar M., Singh M., Frank I. E., Patibandla P. K., Tyagi N., Rai J., Metreveli N., Rodriguez W. E., Tseng M. T., Tyagi S. C., Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia. American Journal of Physiology: Heart and Circulatory Physiology 2008 295 2 H890 H897 2-s2.0-52449119107 10.1152/ajpheart.00099.2008
36. Chen F. Y., Guo Y. H., Gao W., Feng X. H., Chen L., Tang C. S., Effect of hyperhomocysteinemia on cardiac remodeling in rats. Beijing Da Xue Xue Bao 2006 38 2 179 183
37. de Andrade C. R., Tirapelli C. R., Haddad R., Eberlin M. N., Ramalho L. N. Z., Iyomasa M. M., Uyemura S. A., de Oliveira A. M., Hyperhomocysteinemia induced by feeding rats diets rich in dl-homocysteine thiolactone promotes alterations on carotid reactivity independent of arterial structure. Vascular Pharmacology 2009 51 4 291 298 2-s2.0-70349855181 10.1016/j.vph.2009.07.004
38. Jakubowski H., Zhang L., Bardeguez A., Aviv A., Homocysteine thiolactone and protein homocysteinylation in human endothelial cells implications for atherosclerosis. Circulation Research 2000 87 1 45 51 2-s2.0-0034617073 (Pubitemid 30456934)
39. Wang H., Yoshizumi M., Lai K., Tsai J.-C., Perrella M. A., Haber E., Lee M.-E., Inhibition of growth and p21(ras) methylation in vascular endothelial cells by homocysteine but not cysteine. The Journal of Biological Chemistry 1997 272 40 25380 25385 2-s2.0-0030610589 10.1074/jbc.272.40.25380 (Pubitemid 27415732)
40. Hajjar K. A., Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. Journal of Clinical Investigation 1993 91 6 2873 2879 2-s2.0-0027288252 (Pubitemid 23182548)
41. Starkebaum G., Harlan J. M., Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. Journal of Clinical Investigation 1986 77 4 1370 1376 2-s2.0-0022552919 (Pubitemid 16047161)
42. Miller A., Mujumdar V., Palmer L., Bower J. D., Tyagi S. C., Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. American Journal of Hypertension 2002 15 2 157 163 2-s2.0-0036182632 10.1016/S0895-7061(01)02286-5 (Pubitemid 34161091)
43. Sood H. S., Cox M. J., Tyagi S. C., Generation of nitrotyrosine precedes activation of metalloproteinase in myocardium of hyperhomocysteinemic rats. Antioxidants and Redox Signaling 2002 4 5 799 804 2-s2.0-0036774355 (Pubitemid 35246943)
44. Muntzel M. S., Joseph T., Onwumere O., Acute homocysteine administration does not elevate sympathetic nerve activity in rats. Atherosclerosis 2006 184 2 290 294 2-s2.0-30044440193 10.1016/j.atherosclerosis.2005.04.009 (Pubitemid 43049712)
45. Sammut I. A., Foresti R., Clark J. E., Exon D. J., Vesely M. J. J., Sarathchandra P., Green C. J., Motterlini R., Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. British Journal of Pharmacology 1998 125 7 1437 1444 2-s2.0-0031767014 (Pubitemid 28548555)
46. Jakubowski H., Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. Journal of Nutrition 2000 130 377 381 2-s2.0-0033981289
47. Jakubowski H., Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. The FASEB Journal 1999 13 15 2277 2283 2-s2.0-0032778517
48. Głowacki R., Jakubowski H., Cross-talk between Cys34 and lysine residues in human serum albumin revealed by N-homocysteinylation. The Journal of Biological Chemistry 2004 279 12 10864 10871 2-s2.0-2442641844 10.1074/jbc.M313268200 (Pubitemid 38401576)
49. Perła-Kaján J., Marczak Ł., Kaján L., Skowronek P., Twardowski T., Jakubowski H., Modification by homocysteine thiolactone affects redox status of cytochrome c. Biochemistry 2007 46 21 6225 6231 2-s2.0-34249725607 10.1021/bi602463m (Pubitemid 46842865)
50. Sauls D. L., Lockhart E., Warren M. E., Lenkowski A., Wilhelm S. E., Hoffman M., Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia. Biochemistry 2006 45 8 2480 2487 2-s2.0-33644553466 10.1021/bi052076j
51. Sibrian-Vazquez M., Escobedo J. O., Lim S., Samoei G. K., Strongin R. M., Homocystamides promote free-radical and oxidative damage to proteins. Proceedings of the National Academy of Sciences of the United States of America 2010 107 2 551 554 2-s2.0-76249084482 10.1073/pnas.0909737107
52. Paoli P., Sbrana F., Tiribilli B., Caselli A., Pantera B., Cirri P., De Donatis A., Formigli L., Nosi D., Manao G., Camici G., Ramponi G., Protein N-homocysteinylation induces the formation of toxic amyloid-like protofibrils. Journal of Molecular Biology 2010 400 4 889 907 2-s2.0-77954357800 10.1016/j.jmb.2010.05.039
53. Undas A., Perła J., Łacinski M., Trzeciak W., Kaźmierski R., Jakubowski H., Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosis. Stroke 2004 35 6 1299 1304 2-s2.0-2542618547 10.1161/01.STR.0000128412.59768.6e (Pubitemid 38697447)
54. Jakubowski H., Boers G. H. J., Strauss K. A., Mutations in cystathionine β -synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans. The FASEB Journal 2008 22 12 4071 4076 2-s2.0-57349180605 10.1096/fj.08-112086
55. Undas A., Jankowski M., Twardowska M., Padjas A., Jakubowski H., Szczeklik A., Antibodies to N-homocysteinylated albumin as a marker for early-onset coronary artery disease in men. Thrombosis and Haemostasis 2005 93 2 346 350 2-s2.0-13844253976 10.1160/TH04-08-0493 (Pubitemid 40253742)
56. Jakubowski H., Anti-N-homocysteinylated protein autoantibodies and cardiovascular disease. Clinical Chemistry and Laboratory Medicine 2005 43 10 1011 1014 2-s2.0-27744574426 10.1515/CCLM.2005.177 (Pubitemid 41581953)
57. Chwatko G., Jakubowski H., The determination of homocysteine-thiolactone in human plasma. Analytical Biochemistry 2005 337 2 271 277 2-s2.0-13244287981 10.1016/j.ab.2004.11.035 (Pubitemid 40187254)
58. Chwatko G., Boers G. H. J., Strauss K. A., Shih D. M., Jakubowski H., Mutations in methylenetetrahydrofolate reductase or cystathionine β -syntase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice. The FASEB Journal 2007 21 8 1707 1713 2-s2.0-34249775796 10.1096/fj.06-7435com (Pubitemid 46855616)
59. Jakubowski H., The determination of homocysteine-thiolactone in biological samples. Analytical Biochemistry 2002 308 1 112 119 2-s2.0-0036750807 10.1016/S0003-2697(02)00224-5 (Pubitemid 35191644)
60. Abramochkin D. V., Haertdinov N. N., Porokhnya M. V., Zefirov A. L., Sitdikova G. F., Carbon monoxide affects electrical and contractile activity of rat myocardium. Journal of Biomedical Science 2011 18 1, article 40 2-s2.0-79958772787 10.1186/1423-0127-18-40
61. Bucci M., Papapetropoulos A., Vellecco V., Zhou Z., Zaid A., Giannogonas P., Cantalupo A., Dhayade S., Karalis K. P., Wang R., Feil R., Cirino G., cGMP-dependent protein kinase contributes to hydrogen sulfide-stimulated vasorelaxation. PLoS One 2012 7 12 e53319
62. Huang Y. E., Tang Z. H., Xie W., Shen X. T., Liu M. H., Peng X. P., Zhao Z. Z., Nie D. B., Liu L. S., Jiang Z. S., Endogenous hydrogen sulfide mediates the cardioprotection induced by ischemic postconditioning in the early reperfusion phase. Experimental and Therapeutic Medicine 2012 4 6 1117 1123
63. Djurić D., Vušanović A., Jakovljević V., The effects of folic acid and nitric oxide synthase inhibition on coronary flow and oxidative stress markers in isolated rat heart. Molecular and Cellular Biochemistry 2007 300 1-2 177 183 2-s2.0-34250012359 10.1007/s11010-006-9381-6 (Pubitemid 46881827)
64. Jakovljevic V. L., Djordjevic D. Z., Djuric D. M., The effects of vitamin C and nitric oxide synthase inhibition on coronary flow and oxidative stress markers in isolated rat heart. General Physiology and Biophysics 2011 30 3 293 300 2-s2.0-80054099715 10.4149/gpb-2011-03-293
65. Kimura Y., Kimura H., Hydrogen sulfide protects neurons from oxidative stress. The FASEB Journal 2004 18 10 1165 1167 2-s2.0-9444263079 10.1096/fj.04-1815fje (Pubitemid 39561558)
66. Geng B., Chang L., Pan C., Qi Y., Zhao J., Pang Y., Du J., Tang C., Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochemical and Biophysical Research Communications 2004 318 3 756 763 2-s2.0-2442499521 10.1016/j.bbrc.2004.04.094 (Pubitemid 38624219)
67. Módis K., Asimakopoulou A., Coletta C., Papapetropoulos A., Szabo C., Oxidative stress suppresses the cellular bioenergetic effect of the 3-mercaptopyruvate ulfurtransferase/hydrogen sulfide pathway. Biochemical and Biophysical Research Communications 2013 433 4 401 407
68. Kimura Y., Goto Y.-I., Kimura H., Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxidants and Redox Signaling 2010 12 1 1 13 2-s2.0-71549130783 10.1089/ars.2008.2282
69. Nagahara N., Nirasawa T., Yoshii T., Niimura Y., Is novel signal transducer sulfur oxide involved in the redox cycle of persulfide at the catalytic site cysteine in a stable reaction intermediate of mercaptopyruvate sulfurtransferase? Antioxidants and Redox Signaling 2012 16 8 747 753 2-s2.0-84857623740 10.1089/ars.2011.4468
70. Nagahara N., Yoshii T., Abe Y., Matsumura T., Thioredoxin-dependent enzymatic activation of mercaptopyruvate sulfurtransferase: an intersubunit disulfide bond serves as a redox switch for activation. The Journal of Biological Chemistry 2007 282 3 1561 1569 2-s2.0-33847335589 10.1074/jbc.M605931200 (Pubitemid 47076697)
71. Mikami Y., Shibuya N., Kimura Y., Nagahara N., Ogasawara Y., Kimura H., Thioredoxin and dihydrolipoic acid are required for 3-mercaptopyruvate sulfurtransferase to produce hydrogen sulfide. Biochemical Journal 2011 439 3 479 485 2-s2.0-80054015725 10.1042/BJ20110841
72. Kajimura M., Shimoyama M., Tsuyama S., Suzuki T., Kozaki S., Takenaka S., Tsubota K., Oguchi Y., Suematsu M., Visualization of gaseous monoxide reception by soluble guanylate cyclase in the rat retina. The FASEB Journal 2003 17 3 506 508 2-s2.0-0037364673
73. Soni H., Patel P., Rath A. C., Jain M., Mehta A. A., Cardioprotective effect with carbon monoxide releasing molecule-2 (CORM-2) in isolated perfused rat heart: role of coronary endothelium and underlying mechanism. Vascular Pharmacology 2010 53 1-2 68 76 2-s2.0-77952430830 10.1016/j.vph.2010.04.002